Summary
3H-Domperidone (3H-DOMP) binding sites were compared in rat striatum and pituitary, regarding the effects of the non-hydrolysable GTP analog, Gpp(NH)p and inhibition by various dopamine (DA) antagonists. Gpp(NH)p (0.1 mM) elicited in both tissues a rightward shift in DA concentration-inhibition curves, but the changes in either IC50 values or pseudo-Hill coefficients were larger in pituitary than in striatum. Computer analysis of the data showed that, in the presence of Gpp(NH)p, the curve obtained in striatum is best explained by the presence of two classes of binding site, a high-affinity site (K i=95 nM, 27% of total binding) and a low-affinity site (K i=5, 100 nM, 73% of total binding), whereas in pituitary only a low-affinity site (K i=5,070 nM) could be detected.
In striatum, several discriminant benzamide derivatives (DBD), (−)-sulpiride and recently developped compounds, allowed to distinguish two components among 3H-DOMP binding sites: a high-affinity site representing one-third of total binding and a low-affinity component displaying a 8–17 fold lower affinity. Classical neuroleptics like haloperidol, chlorpromazine and metoclopramide inhibited striatal 3H-DOMP binding in a monophasic manner. In pituitary a single component could be detected for all tested antagonists including the DBD and K i values for the latters were identical to those found for the low-affinity component in striatum.
Gpp(NH)p (0.1 mM) had no effect on the biphasic inhibition of striatal binding by the most discriminant compound RIV 2093, suggesting that the presence of two components for this DBD is not related to the two conformational states of the D-2 receptor. Also the discriminant property of RIV 2093 is not related to its binding to a sodium-dependent site, since the sodium effects (leftward shift of the inhibition curve) are very similar for RIV 2093 and the non discriminant substituted benzamide metoclopramide.
It is concluded that, in addition to a fully GTP-sensitive site, analogous to the D-2 receptor detected in pituitary, striatum also contains a distinct class of binding site, not or less affected by GTP, for which DBD display a high affinity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baudry M, Martres MP, Schwartz JC (1979) 3H-Domperidone: a selective ligand for dopamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 308:231–237
Caron MG, Beaulieu, M, Raymond V, Gagne B, Drouin J, Lefkowitz RJ, Labrie F (1978) Dopaminergic receptors in the anterior pituitary gland. J Biol Chem 253:2244–2253
Cheng YC, Prussoff WH (1973) Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Creese I, Sibley DR (1982) Comments on the commentary by Dr. Seeman. Biochem Pharmacol 31:2568–2569
De Lean A, Kilpatrick BF, Caron M (1982) Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists. Mol Pharmacol 22:290–297
Enjalbert A, Bockaert J (1983) Pharmacological characterization of the D-2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 25:576–584
Furth J, Clifton KH (1958) Experimental pituitary tumors. Endocrinology Proc 12:3–18
Heikkila RE, Cabbat FS (1983) Ascorbate-induced lipid peroxidation and inhibition of 3H-spiroperidol binding in neostriatal membrane preparations. J Neurochem 41:1384–1392
Jenner P, Marsden CD (1981) substituted benzamide drugs as selective neuroleptics. Neuropharmacology 20:1285–1293
Jenner P, Theodorou A, Marsden CD (1982) Specific receptors for substituted benzamide drugs in brain. In: Stanley M, Rostrosen J (eds) The benzamides. Pharmacology, neurobiology and clinical aspects, vol 35. Raven Press, New York, pp 109–141
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Langer SZ, Arbilla S, Kamal L, Cantrill R (1983) Peripheral and central dopamine receptors modulating the release of neurotransmitters. In: Carlsson A, Lars J, Nilson G (eds) Dopamine receptor agonists. Swedisch Pharmaceutical Press, Stockholm, suppl 1, pp 108–117
Legan SJ, Allyn Coon G, Karsch FJ (1975) Role of oestrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology 96:50–56
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Martres MP, Sokoloff P, Delandre M, Schwartz JC, Protais P, Costentin J (1984) Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 325:102–115
Molinoff PB, Wolfe BB, Weiland GA (1981) Quantitative analysis of drug-receptor interactions. II. Determination of the properties of receptor subtypes. Life Sci 29:427–443
Onalli P, Schwartz JP, Costa E (1981) Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. Proc Natl Acad Sci USA 78:6531–6534
Parker RB, Waud DR (1971) Pharmacological estimation of drug receptor dissociation — Statistical evaluation. I. Agonists. J Pharmacol Exp Ther 177:1–12
Protais P, Costentin J, Schwartz JC (1976) Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50:1–6
Protais P, Bonnet JJ, Costentin J (1983a) Pharmacological characterization of the receptors involved in the apomorphine induced polyphasic modifications of locomotor activity in mice. Psychopharmacology 81:126–134
Protais P, Dubuc I, Costentin J (1983b) Pharmacological characteristics of dopamine receptors involved in the dual effects of dopamine agonists on yawning behaviour in rats. Eur J Pharmacol 94:271–280
Scatton B (1982) Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity. J Pharmacol Exp Ther 220:197–202
Schwartz JC, Sokoloff P, Martres MP, Protais P, Costentin J, Bouthenet ML, Sales N (1983) Distinction of dopamine receptors well recognised by antipsychotics agents: binding, autoradiographic and behavioural studies. In: Carlsson A, Lars J, Nilsson G (eds) Dopamine receptor agonists. Acta Pharmaceutica Suecica. Swedish Pharmaceutical Press, Stockholm, suppl 1, pp 47–59
Sibley DR, Creese I (1983) Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors. Mol Pharmacol 23:585–593
Sibley DR, De Lean A, Creese I (1982) Anterior pituitary dopamine receptors. Demonstration of interconvertible high- and low-affinity states of the D-2 dopamine receptor. J Biol Chem 257:6351–6361
Sokoloff P, Martres MP, Schwartz JC (1980) Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone. Naunyn-Schmiedeberg's Arch Pharmacol 315:89–102
Starke K, Spath L, Lang JD, Adelung C (1983) Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in rabbit caudate nucleus. Naunyn-Schmiedeberg's Arch Pharmacol 323:298–306
Stefanini E, Marchisio AM, Devoto P, Vernaleone F, Collu R, Spano PF (1980) Sodium-dependent interaction of benzamides with dopamine receptors. Brain Res 198:229–233
Weiner RI, Cronin MJ, Cheung CY, Faure N, Clark BR, Goldsmith PC (1979) Anterior pituitary dopamine receptors and prolactin secretion. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon Press, New York, pp 1218–1220
Zahniser NR, Dubocovich ML (1983) Comparison of dopamine receptor sites labeled by 3H-S-sulpiride and 3H-spiperone in striatum. J Pharmacol Exp Ther 227:592–599
Zahniser NR, Molinoff PB (1978) Effect of guanine nucleotides on striatal dopamine receptors. Nature 275:453–454
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sokoloff, P., Martres, MP., Delandre, M. et al. 3H-domperidone binding sites differ in rat striatum and pituitary. Naunyn-Schmiedeberg's Arch. Pharmacol. 327, 221–227 (1984). https://doi.org/10.1007/BF00502453
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00502453